Ann Neurol

1. ABOSEIF A, Cacciaguerra L, Vilaseca A, Kondrakunta S, et al
   Selective Limbic and Striatal Atrophy Corresponds to Regional Gene Expression in Leucine-Rich Glioma-Inactivated-1 Immunoglobulin G Autoimmune Encephalitis.
   Ann Neurol. 2026 Oct 6. doi: 10.1002/ana.78389.
   

   >> Share

   
   
2. AHOLA V, Saraste M, Pedrini E, Tuomaala J, et al
   Serum Chitotriosidase Links to Activated Glia at Chronic Active Lesion Rims in Multiple Sclerosis Brain.
   Ann Neurol. 2026 Oct 6. doi: 10.1002/ana.78386.
   

   >> Share

   
   

   
   BMC Neurol

3. ELMAZNY A, Shehata MH, Elsebaie EH, Moamen S, et al
   Multiple sclerosis knowledge among primary care physicians practicing in primary health centers in Bahrain: a cross-sectional study.
   BMC Neurol. 2026;26:633.
   

   >> Share

   
   
4. UCAROGLU CAN N, Kotan D
   Elevated atherogenic index of plasma in multiple sclerosis: association with metabolic profile in a cross-sectional study.
   BMC Neurol. 2026;26:640.
   

   >> Share

   
   

   
   Brain

5. UHER T, Nagels G
   Mapping brain imaging heterogeneity in multiple sclerosis.
   Brain. 2026 Oct 8:awag349. doi: 10.1093.
   

   >> Share

   
   

   
   Diabet Med

6. BLACK R, Hasson F, King L, Davies M, et al
   Impact of diabetes mellitus on the menopausal experience: A scoping review.
   Diabet Med. 2026 Aug 22:e70420. doi: 10.1111/dme.70420.
   

   >> Share

   
   
7. BRITTEN FL, Shipton E, Duke M, Duncan EL, et al
   A systematic review of breastfeeding prevalence, duration and determining factors in women with type 1 and type 2 diabetes mellitus.
   Diabet Med. 2026 Jul 28:e70315. doi: 10.1111/dme.70315.
   

   >> Share

   
   
8. MULLEY JF
   Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.
   Diabet Med. 2026 Jul 2:e70412. doi: 10.1111/dme.70412.
   

   >> Share

   
   
9. GOLDING JA, Long SO, Hope SV, Wright JE, et al
   The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study.
   Diabet Med. 2026 Jun 23:e70406. doi: 10.1111/dme.70406.
   

   >> Share

   
   
10. COCKCROFT EJ, Bright C, Nathan H, Farrow D, et al
    Barriers and enablers to physical activity in type 1 diabetes: A mixed-methods study of adults and parent-reported child perspectives in the UK.
    Diabet Med. 2026 Jun 19:e70378. doi: 10.1111/dme.70378.
    

    >> Share

    
    
11. MITCHELL S, Patwardhan K, Lucocq J, Geropoulos G, et al
    Metabolic and bariatric surgery for patients with obesity type 1 diabetes mellitus: A comprehensive updated systematic review and meta-analysis.
    Diabet Med. 2026 Mar 28:e70305. doi: 10.1111/dme.70305.
    

    >> Share

    
    
12. ANSON M, Zhao SS, Gao Y, Zhang Y, et al
    Progression to type 1 diabetes across the autoimmunity and glycaemia continuum: Insights from real-world paediatric and adult cohorts.
    Diabet Med. 2026 Oct 7:e70492. doi: 10.1111/dme.70492.
    

    >> Share

    
    

    
    Diabetes Res Clin Pract

13. ALRAMADNEH TN, Kubaev A, Saeed SM, Kumar N, et al
    From beta-cell stress to tertiary lymphoid structure formation: a stage-dependent framework for interpreting type 1 diabetes progression.
    Diabetes Res Clin Pract. 2026;241:113547.
    

    >> Share

    
    
14. YASMIN M, Ghosh S
    National health policy for diabetes in children in India: The West Bengal model transforming type 1 diabetes care in India.
    Diabetes Res Clin Pract. 2026;241:113546.
    

    >> Share

    
    
15. BLOUNT S, Zicari A, Eiland L, Knezevich E, et al
    Type 1 diabetes mellitus in the rural United States: a scoping review of definitions, healthcare delivery, and patient outcomes.
    Diabetes Res Clin Pract. 2026;241:113501.
    

    >> Share

    
    
16. DI MOLFETTA S, Pitocco D, Assaloni R, Baratta R, et al
    Optimizing the use of the Omnipod 5 system in adults with type 1 diabetes: an Italian expert Delphi consensus.
    Diabetes Res Clin Pract. 2026;241:113577.
    

    >> Share

    
    
17. YANG Z, Wei X, Jiang S, Sun S, et al
    Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990-2023.
    Diabetes Res Clin Pract. 2026;241:113524.
    

    >> Share

    
    

    
    Intern Med

18. OSHIMA Y, Saito N, Kawaguchi T, Okayama M, et al
    A Case of Insulin Autoimmune Syndrome Complicated by IgG4-Related Disease, Both Successfully Treated with Corticosteroids.
    Intern Med. 2026 Oct 8. doi: 10.2169/internalmedicine.7479.
    

    >> Share

    
    

    
    J Autoimmun

19. RUGGE M, Genta RM, Graham DY
    Autoimmune gastritides: A critical review.
    J Autoimmun. 2026;164:103642.
    

    >> Share

    
    
20. VELLAS D, Berges A, De Rycke Y, Pinto S, et al
    Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data.
    J Autoimmun. 2026;164:103639.
    

    >> Share

    
    

    
    J Neurol

21. GILHUS NE, Melsom SC, Bugge C
    Healthcare costs and burden of myasthenia gravis for patients and society: a systematic review.
    J Neurol. 2026;273:648.
    

    >> Share

    
    
22. MASUDA Y, Matsuda S, Okazaki A, Tsuge R, et al
    Clinical features and prognosis of EGPA-associated peripheral neuropathy: a multicentre REVEAL cohort study.
    J Neurol. 2026;273:641.
    

    >> Share

    
    
23. PALAZZO L, Clarelli F, Giordano A, Ferre L, et al
    Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis.
    J Neurol. 2026;273:640.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

24. STRUCKMEYER N, Landsberg S, Biester T, Doelle RM, et al
    Menstrual cycle-related variations in insulin requirements and glycemic control during automated insulin delivery in adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2026;39:990-999.
    

    >> Share

    
    
25. YASAR A, Dursun F, Altun EE, Kirmizibekmez H, et al
    Ready for transition, but ready for outcomes? Discordance between transition readiness and metabolic control in adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2026;39:1000-1006.
    

    >> Share

    
    
26. PUDIG L, Greifoner L, Dieke M, Vilser C, et al
    Autoimmune adrenalitis in adolescents in Germany: a series of 4 cases.
    J Pediatr Endocrinol Metab. 2026 Oct 5. doi: 10.1515/jpem-2026-0187.
    

    >> Share

    
    
27. CHEN S, Glaser N, Loomba L, Schulmeister C, et al
    Subcutaneous insulin treatment for mild pediatric diabetic ketoacidosis: an evaluation of treatment duration and length of stay.
    J Pediatr Endocrinol Metab. 2026;39:1046-1050.
    

    >> Share

    
    

    
    Mult Scler

28. LEE NJ, Beu AM, Amezcua L, Mateen FJ, et al
    Multiple sclerosis and housing insecurity or forcible displacement: A scoping review.
    Mult Scler. 2026 Oct 8:13524585261492505. doi: 10.1177/13524585261492505.
    

    >> Share

    
    
29. MARIOTTINI A, Ginestroni A, Carlesi E, Di Pasquale F, et al
    Autologous haematopoietic stem cell transplantation affects paramagnetic rim lesions in multiple sclerosis.
    Mult Scler. 2026 Oct 8:13524585261489061. doi: 10.1177/13524585261489061.
    

    >> Share

    
    
30. PATEL SG, Brownlee WJ
    Monogenic disorders of immune regulation presenting with neurological autoimmunity.
    Mult Scler. 2026 Oct 8:13524585261490254. doi: 10.1177/13524585261490254.
    

    >> Share

    
    

    
    N Engl J Med

31. BAI X, Xu C, Yang H
    Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
    N Engl J Med. 2026;395:1458-1459.
    

    >> Share

    
    
32. KUCUK H, Erden A, Tufan A
    Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
    N Engl J Med. 2026;395:1458.
    

    >> Share

    
    
33. UHLIG HH, Hambleton S, Travis S
    Interleukin-10 Autoantibodies in Inflammatory Bowel Disease. Reply.
    N Engl J Med. 2026;395:1459.
    

    >> Share

    
    
34. ANTONIOLI L
    Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
    N Engl J Med. 2026;395:1457-1458.
    

    >> Share

    
    

    
    Nat Rev Neurol

35. KIANI L
    EBV reactivation precedes multiple sclerosis relapse.
    Nat Rev Neurol. 2026 Oct 9. doi: 10.1038/s41582-026-01280.
    

    >> Share

    
    

    
    Neurol Clin Pract

36. PIHL-JENSEN G, Selle ML, Aarseth JH, Myhr KM, et al
    Infection Risk During Rituximab Therapy in Multiple Sclerosis: Effect of Dosing Interval and Age.
    Neurol Clin Pract. 2026;16:e200664.
    

    >> Share

    
    

    
    Neurology

37. EL MAHDAOUI S, Pontieri L, Romme Christensen J, Alabdalridha H, et al
    Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.
    Neurology. 2026;107:e218545.
    

    >> Share

    
    
38. SEGAL Y, Aksamit AJ, McCarter SJ, Syc-Mazurek SB, et al
    "Railroad Track" Brain Fluorodeoxyglucose-PET Sign in Antiphospholipid Syndrome-Related Posterior Cortical Atrophy.
    Neurology. 2026;107:e218621.
    

    >> Share

    
    

    
    PLoS One

39. WANG J, Yin Y, Qu J, Tao Z, et al
    Systematic review and network meta-analysis of performance of the Sapporo criteria, the Revised Sapporo criteria, and the 2023 ACR/EULAR APS classification criteria for patients with antiphospholipid syndrome: A protocol.
    PLoS One. 2026;21:e0359310.
    

    >> Share

    
    
40. YU Y, Banker M, Sherr J, Scholtens DM, et al
    Empirical transition probability modeling of continuous glucose monitoring data.
    PLoS One. 2026;21:e0358361.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share